Department of Pharmacy Practice

College of Pharmacy
masthead

Monsheel Sodhi

 Monsheel Sodhi Monsheel Sodhi, MRPharmS, PhD
Assistant Professor
Department of Pharmacy Practice
Email mssodhi@uic.edu
Phone 312-355-5949
Fax 312-413-9303
Office 3102 MBRB
US Mail 900 South Ashland, Room 3102 MBRB MC870, Chicago, IL 60612

Research Interests
Dr. Sodhi's areas of interest include the contribution of genetic, epigenetic, and post-transcriptional variation to the etiologies of major psychiatric disorders and suicide; and the pharmacogenetics of schizophrenia
and mood disorders.

Education
Bachelor of Pharmacy, University of London, London, United Kingdom
Master of Science in Neuroscience, University of London, London, United Kingdom
PhD in Genetics, Institute of Psychiatry, University of London, London, United Kingdom
Postdoctoral training completed at the University of Oxford, United Kingdom and the Department of Pharmacology at Vanderbilt University

Current UIC Appointments
Assistant Professor, Department of Pharmacy Practice
Representative Publications
  1. SODHI MS, SIMMONS M, MCCULLUMSMITH R, HAROUTUNIAN V, MEADOR-WOODRUFF JH (2011). Glutamatergic Gene Expression Is Specifically Reduced in Thalamocortical Projecting Relay Neurons in Schizophrenia. Biol Psychiatry. [Epub ahead of print]
  2. SIMMONS M, MEADOR-WOODRUFF JH, SODHI MS (2010). Increased cortical expression of an RNA editing enzyme occurs in major depressive suicide victims. Neuroreport 21(15):993-7.
  3. ROTH TL, LUBIN FD, SODHI M, KLEINMAN JE (2009). Epigenetic mechanisms in schizophrenia. Biochim Biophys Acta. 1790(9):869-77.
  4. SODHI M, WOOD KH, MEADOR-WOODRUFF J (2008). Role of glutamate in schizophrenia: integrating excitatory avenues of research. Expert Rev Neurother. 8(9):1389-406
  5. SODHI MS, AIREY DC, LAMBERT W, BURNET PW, HARRISON PJ, SANDERS-BUSH E (2005). A rapid new assay to detect RNA editing reveals antipsychotic-induced changes in serotonin-2C transcripts. Mol Pharmacol. 68(3):711-9.
  6. SODHI MS, SANDERS-BUSH E (2004). Serotonin and brain development. Int Rev Neurobiol. 2004;59:111-74.
  7. TUNBRIDGE, E., P. W. BURNET, SODHI MS, HARRISON PJ (2004). "Catechol-o-methyltransferase(COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression." Synapse 51(2):112-8.
  8. SODHI MS, BURNET PJ, MAKOFF AJ and HARRISON PJ.(2001): Reduced mRNA editing of the human 5-HT2C receptor in schizophrenia. Molecular Psychiatry, 6 (4), 373-9.
  9. ARRANZ MJ, MUNRO J, BIRKETT J, BOLONNA A, MANCAMA D, SODHI MS, et al. (2000): Pharmacogenetic prediction of clozapine response. Lancet 355: 1615 - 1616.
  10. ARRANZ MJ, ERDMANN J, KIROV G, RIETSCHEL M, SODHI M, et al (1997). 5-HT2A receptor and bipolar affective disorder: Association studies in affected patients. Neurosci Lett 224 (2): 95-98.
  11. COLLIER D, ARRANZ M, SHAM P, BATTERSBY S, GILL P, AITCHISON KJ, SODHI MS, et al. (1996):The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. NeuroReport7:1675-1679.
  12. ARRANZ MJ, COLLIER DA, MUNRO J, SHAM P, KIROV G, SODHI MS, ROBERTS GW, PRICE J, AND KERWIN RW (1996): Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neuroscience Letters 217:177-178.
  13. SODHI MS, ARRANZ MJ, CURTIS DA, SHAM PC, BALL DM, ROBERTS GW, PRICE J, COLLIER DA AND KERWIN RW (1995): Association between clozapine response and allelic variation in the 5- HT2C receptor gene. NeuroReport 7: 369-375.
  14. ARRANZ MJ, COLLIER D, SODHI MS, BALL DM, ROBERTS GW, PRICE J, SHAM P AND KERWIN R.1995): Association between clozapine response and allelic variation in the 5-HT2A receptor gene. Lancet, 346: 281-282.

Click here to view Dr. Sodhi's on-line CV. PDF logo

For more information about the Sodhi laboratory, please click here

Return to faculty list